Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predictive Proteomic Factors of Response to Radiochemotherapy in Esophageal Cancer
NCT00911092Phase 4Completed
- Sponsor
- Centre Oscar Lambret
- Start
- Oct 2007
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fluorouracil, cisplatin in esophageal cancer, sponsored by Centre Oscar Lambret. Started Oct 2007; status: completed.
02
Drugs
fluorouracilcisplatin
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT00911092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00911092.